228401-47-6 Usage
Uses
Used in Pharmaceutical Industry:
2,4-DIMETHOXY-5-(TRIFLUOROMETHYL)ANILINE is used as an intermediate in the synthesis of new drugs for various therapeutic purposes. Its unique structure allows for the development of innovative pharmaceutical agents with potential applications in treating a range of medical conditions.
Used in Agrochemical Industry:
In the agrochemical sector, 2,4-DIMETHOXY-5-(TRIFLUOROMETHYL)ANILINE is utilized as a building block for the creation of novel agrochemicals. Its properties make it suitable for the development of new pesticides, herbicides, and other agricultural chemicals that can improve crop protection and yield.
Used in Dye and Pigment Production:
2,4-DIMETHOXY-5-(TRIFLUOROMETHYL)ANILINE is used as an intermediate in the production of dyes and pigments. Its chemical structure contributes to the color and stability of these products, making it a valuable component in the formulation of various dyes and pigments for different industries.
Used in Organic Synthesis:
As a key intermediate in organic synthesis, 2,4-DIMETHOXY-5-(TRIFLUOROMETHYL)ANILINE is employed in the preparation of a variety of organic compounds. Its versatility in chemical reactions makes it an essential component in the synthesis of complex organic molecules for research and industrial applications.
Check Digit Verification of cas no
The CAS Registry Mumber 228401-47-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,2,8,4,0 and 1 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 228401-47:
(8*2)+(7*2)+(6*8)+(5*4)+(4*0)+(3*1)+(2*4)+(1*7)=116
116 % 10 = 6
So 228401-47-6 is a valid CAS Registry Number.
228401-47-6Relevant articles and documents
Positive allosteric modulators of the nicotinic acetylcholine receptor
-
Page 29, 30, (2010/02/05)
The invention provides compounds of Formula I: These compounds may be in the form of pharmaceutical salts or compositions, may be in pure enantiomeric form or racemic mixtures, and are useful in pharmaceuticals used to treat diseases or conditions in which α7 nAChR is known to be involved.
